Oligosaccharides in infant nutrition are gut-strengthening nutrition that has been systematically proven to support the infant's immunity and digestion system. In last few years, with increasing consumer inclination towards gut health, it has grown as an issue for numerous people all around the globe. Therefore, 75 percent of the consumers consume those foods promoting a healthy microbiome, and around 56 percent of the consumers like to consume those foods because they digest better. As a result, the demand for oligosaccharides increases in preparing infant formulas because of several qualities such as prebiotic effects, memory improvement, infection prevention, gut health maintenance, and brain growth.
According to Data Bridge Market Research the Oligosaccharides in Infant Nutrition Market witnessed a healthy CAGR of 9.00% from 2022 to 2029.
"Rising popularity of human milk oligosaccharides is expected to drive the market growth"
Human milk oligosaccharides are gaining high popularity for the development and growth of infant because of their potential benefits which are associated with its consumption, such as providing human milk oligosaccharides (HMOs) as a prebiotic to support in maintaining an healthy immune system in infants. This oligosaccharide also aids to improving gut colonization and also prevent form microbial pathogen and foreign particle from adhering to epithelial surfaces. Human milk oligosaccharides (HMOs) are a healthier option for non-lactating mothers because they include all the required nutrients and are essential for the normal growth of infants. Thus, as a result of many benefits and high popularity of human milk oligosaccharides is anticipated to drive the growth of the oligosaccharides in infant nutrition market.
What restraints the growth of oligosaccharides in infant nutrition market?
"Increasing government initiatives to boost breastfeeding over formula"
Growing government initiatives to increase breastfeeding over formula based feeding is projected to hinder the market's growth. The American Academy of Pediatrics and US Dietary Rules for Americans endorse exclusive breastfeeding alert icons for approximately six months and then continuing the breastfeeding until the child is 12 months old or older while introducing other foods alert icons. Furthermore, the natural breastfeeding human milk oligosaccharides (HMOs) supports growth and development more than the artificial synthesized human milk oligosaccharides (HMOs) which will also hamper the market growth.
Segmentation: Oligosaccharides in Infant Nutrition Market
The oligosaccharides in infant nutrition market is segmented on the basis of source, type and form.
- 根據來源，嬰兒營養市場中的寡糖為細菌、植物、藻類、真菌。
- 根據類型，嬰兒營養市場中的低聚醣為半乳寡糖、母乳寡糖、低聚果糖。
- 根據形態，嬰兒營養市場中的寡糖分為液體、粉末。
區域洞察：亞太地區可望主導嬰兒營養低聚醣市場
預計亞太地區將主導市場，並且由於人口可支配收入的增長，預計將大幅增長。此外，該地區龐大的母乳低聚醣衍生產品客戶群將進一步推動嬰兒營養市場中寡糖的成長。
此外，由於北美地區對糖果生產中偶爾使用的卡路里甜味劑的需求不斷增加，該地區在 2022 年至 2029 年的預測期內可能會實現最高的增長率。此外，每年嬰兒人口的大量成長將增加嬰兒營養對寡糖的需求，並對市場成長產生正面影響。
要了解有關該研究的更多信息，請訪問：https://www.databridgemarketresearch.com/reports/global-oligosaccharides-in-infant-nutrition-market
嬰兒營養寡糖市場的主要參與者包括：
- ZuChem Inc.（美國）
- Elicityl SA（法國）
- Jennewein Biotechnologie GmbH（德國）
- 皇家菲仕蘭坎皮納（荷蘭）
- 巴斯夫公司（德國）
- Gnubiotics（瑞士）
- Inbiose NV（比利時）
- Glycom A/S（丹麥）
- Glycosyn LLC（美國）
- 雀巢公司（瑞士）
- 杜邦（美國）
- 帝斯曼（荷蘭）
- 基督徒漢森A/S（丹麥）
- Biosynth Carbosynth（瑞士）
- 香精香料公司（美國）
- 雅培（美國）
- 美多拉克（美國）
以上是報告中涉及的關鍵參與者，要了解更多有關嬰兒營養市場寡糖公司聯繫方式的詳盡列表，請訪問 https://www.databridgemarketresearch.com/contact
研究方法：全球嬰兒營養寡醣市場
資料收集和基準年分析是使用具有大樣本量的資料收集模組完成的。使用市場統計和相干模型來分析和估計市場數據。此外，市場佔有率分析和關鍵趨勢分析是市場報告中的主要成功因素。 DBMR 研究團隊使用的關鍵研究方法是資料三角測量，其中涉及資料探勘、資料變數對市場的影響分析以及初步（產業專家）驗證。除此之外，資料模型還包括供應商定位網格、市場時間軸分析、市場概覽和指南、公司定位網格、公司市場份額分析、測量標準、全球與區域以及供應商份額分析。如有進一步疑問，請要求分析師致電。
